AngioDynamics Statistics
Total Valuation
AngioDynamics has a market cap or net worth of $361.24 million. The enterprise value is $311.65 million.
Important Dates
The next confirmed earnings date is Wednesday, January 8, 2025, before market open.
| Earnings Date | Jan 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AngioDynamics has 40.63 million shares outstanding. The number of shares has increased by 1.86% in one year.
| Current Share Class | 40.63M |
| Shares Outstanding | 40.63M |
| Shares Change (YoY) | +1.86% |
| Shares Change (QoQ) | +0.56% |
| Owned by Insiders (%) | 3.39% |
| Owned by Institutions (%) | 74.21% |
| Float | 37.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.23 |
| Forward PS | 1.23 |
| PB Ratio | 1.85 |
| P/TBV Ratio | 2.99 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.06 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.25, with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.25 |
| Quick Ratio | 1.23 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -77.85% and return on invested capital (ROIC) is -7.60%.
| Return on Equity (ROE) | -77.85% |
| Return on Assets (ROA) | -6.12% |
| Return on Capital (ROIC) | -7.60% |
| Revenue Per Employee | $391,345 |
| Profits Per Employee | -$324,908 |
| Employee Count | 748 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 2.27 |
Taxes
In the past 12 months, AngioDynamics has paid $3.87 million in taxes.
| Income Tax | 3.87M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +16.51% in the last 52 weeks. The beta is 0.67, so AngioDynamics's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | +16.51% |
| 50-Day Moving Average | 7.30 |
| 200-Day Moving Average | 6.75 |
| Relative Strength Index (RSI) | 64.18 |
| Average Volume (20 Days) | 615,849 |
Short Selling Information
The latest short interest is 1.14 million, so 2.81% of the outstanding shares have been sold short.
| Short Interest | 1.14M |
| Short Previous Month | 1.13M |
| Short % of Shares Out | 2.81% |
| Short % of Float | 3.09% |
| Short Ratio (days to cover) | 2.88 |
Income Statement
In the last 12 months, AngioDynamics had revenue of $292.73 million and -$243.03 million in losses. Loss per share was -$6.02.
| Revenue | 292.73M |
| Gross Profit | 151.36M |
| Operating Income | -38.59M |
| Pretax Income | -191.64M |
| Net Income | -243.03M |
| EBITDA | -13.18M |
| EBIT | -38.59M |
| Loss Per Share | -$6.02 |
Full Income StatementBalance Sheet
The company has $55.01 million in cash and $5.42 million in debt, giving a net cash position of $49.58 million or $1.22 per share.
| Cash & Cash Equivalents | 55.01M |
| Total Debt | 5.42M |
| Net Cash | 49.58M |
| Net Cash Per Share | $1.22 |
| Equity (Book Value) | 196.58M |
| Book Value Per Share | 4.79 |
| Working Capital | 95.90M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$20.51 million and capital expenditures -$2.82 million, giving a free cash flow of -$23.33 million.
| Operating Cash Flow | -20.51M |
| Capital Expenditures | -2.82M |
| Free Cash Flow | -23.33M |
| FCF Per Share | -$0.57 |
Full Cash Flow StatementMargins
Gross margin is 51.71%, with operating and profit margins of -13.18% and -83.02%.
| Gross Margin | 51.71% |
| Operating Margin | -13.18% |
| Pretax Margin | -81.70% |
| Profit Margin | -83.02% |
| EBITDA Margin | -4.50% |
| EBIT Margin | -13.18% |
| FCF Margin | n/a |
Dividends & Yields
AngioDynamics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.86% |
| Shareholder Yield | -1.86% |
| Earnings Yield | -67.28% |
| FCF Yield | -6.46% |
Analyst Forecast
The average price target for AngioDynamics is $12.00, which is 34.98% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.00 |
| Price Target Difference | 34.98% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 6.55% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AngioDynamics has an Altman Z-Score of 0.63 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.63 |
| Piotroski F-Score | 3 |